Avinger announces presentations by key opinion leaders at linc 2023

Redwood city, ca / accesswire / june 20, 2023 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced two podium presentations featuring the company's lumivascular technology at the leipzig interventional course (linc) 2023, which took place june 6 through june 9. linc is a leading global forum for new methods and technology in the field of vascular medicine held each year in leipzig, germany.
AVGR Ratings Summary
AVGR Quant Ranking